Presentation TCT 2014 The Case for PCI in Most Patients with Multivessel Disease with and without Diabetes Presenter: George D. Dangas, Michael E. Farkouh, Frederick Feit September 16, 2014
Presentation TCT 2014 The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes Presenter: George D. Dangas, Michael E. Farkouh, David J. Maron September 16, 2014
Presentation TCT 2014 Case Introduction: A Diabetic Patient with Double Vessel Coronary Artery Disease How Should We Treat? Presenter: George D. Dangas, Michael E. Farkouh, Manish A. Parikh September 16, 2014
Presentation TCT 2014 Difficult Bifurcation Lesion Decisions Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab September 16, 2014
Presentation TCT 2014 Difficult Primary PCI Decisions Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab September 16, 2014
Presentation TCT 2014 Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___ Presenter: Bernard Chevalier September 16, 2014
Presentation TCT 2014 TCT 690: Safety and Efficacy of Urgent Transcatheter Aortic Valve Replacement in Patients Admitted with Decompensated Heart Failure Presenter: Howard C. Herrmann, Spencer H. Kubo, Sami Alnasser September 15, 2014
Presentation TCT 2014 Coronary Arteriovenous Fistulae: Assessment and Interventional Decisions Presenter: Ziyad M. Hijazi, John F. Rhodes, Elchanan Bruckheimer September 15, 2014
Presentation TCT 2014 Case #4: Hemodynamic Support Decisions in Cardiogenic Shock Presenter: Emmanouil S. Brilakis, Jose P.S. Henriques, Stefan K. James, Keith G. Oldroyd, Thomas D. Stuckey, William W. O'Neill September 15, 2014
Presentation TCT 2014 Forget Hybrid Do the Whole Thing Robotically! Presenter: Ajay J. Kirtane, David Taggart, Michael DECEASED J. Davidson September 15, 2014
Presentation TCT 2014 Does Cilostazol Have a Role as an Antiplatelet Agent in the Contemporary DES Era (and in Triple Therapy Decisions)? Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Frederick Feit September 14, 2014
Presentation TCT 2014 Physiology Changing Clinical Decision Making: Systematic Use of FFR From the French National Registry Study Presenter: Javier Escaned, Nico H.J. Pijls, Morton J. Kern, Eric Van Belle September 14, 2014
Presentation TCT 2014 Case #2 Results: What Was Done and How the Decision Was Made Presenter: Julie Logan, Marian C. Hawkey, Ashish Pershad September 14, 2014
Presentation TCT 2014 Case #1 Results: What Was Done and How the Decision Was Made Presenter: Julie Logan, Marian C. Hawkey, James B. Hermiller Jr September 14, 2014
Presentation TCT 2014 Imaging Basics: Utilization of CT and Echo for Preprocedural and Periprocedural Decision Making Presenter: Omar K. Khalique September 13, 2014
Presentation TCT 2014 Heart Team Decisions: Who Is the Appropriate Prohibitive-Risk DMR Patient for MitraClip? Presenter: Olaf Franzen, James B. Hermiller Jr, Michael J. Rinaldi, Gorav Ailawadi September 13, 2014
Presentation TCT 2014 The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines? Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Sanjay Kaul September 13, 2014
Presentation TCT 2014 NIRS for Identifying Vulnerable Plaque Prior to Coronary Thrombosis Presenter: Gary S. Mintz, Patrick W. Serruys, Ryan D. Madder, Akiko Maehara September 13, 2014
Presentation TCT 2014 OCT for Identifying Vulnerable Plaque Prior to Coronary Thrombosis Presenter: Gary S. Mintz, Patrick W. Serruys, Ryan D. Madder, Yuji Ikari September 13, 2014
Presentation TCT 2014 NIRS Utility in the Unstable Patient With ACS/NSTEMI Presenter: Gary S. Mintz, Patrick W. Serruys, Ryan D. Madder, David Erlinge September 13, 2014